| Hytham A Kadrie, MD | |
|
721 Glenwood Dr, Ste 467-west, Chattanooga, TN 37404 | |
| (423) 698-3423 | |
| (423) 698-1380 |
| Full Name | Hytham A Kadrie |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 721 Glenwood Dr, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063449486 | NPI | - | NPPES |
| 3163005 | Medicaid | TN | |
| 00139367A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD0000010071 (Tennessee) | Primary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 018034 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Hytham A Kadrie, MD 721 Glenwood Dr, Ste 467-west, Chattanooga, TN 37404 Ph: (423) 698-3423 | Hytham A Kadrie, MD 721 Glenwood Dr, Ste 467-west, Chattanooga, TN 37404 Ph: (423) 698-3423 |
News Archive
Takeda Pharmaceutical Company Limited and Intellikine, Inc. today announced that Takeda America Holdings, Inc., a wholly-owned subsidiary of Takeda, and Intellikine, a privately-held company focused on the discovery and development of innovative, small molecule drugs, have entered into an agreement for Takeda America Holdings to acquire Intellikine by cash.
WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far more expensive than those used to treat drug-susceptible TB.
Some Blue Cross Blue Shield not-for-profit organizations are considering either merging or converting to for-profit status to help them compete with larger insurers in an "increasingly concentrated managed-care industry," the Wall Street Journal reports.
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, will highlight leading patient health and safety initiatives during the 70th annual American Diabetes Association Annual Conference June 26-28 in Orlando, FL.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 2b study designed to evaluate the efficacy and safety of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock.
› Verified 5 days ago
Chelsea Amanda Shugars, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 979 East 3rd Street, Suite C-830, Chattanooga, TN 37403 Phone: 423-778-9001 Fax: 423-778-4692 | |
Dr. George Michael Schmits, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Northgate Park, Suite 201, Chattanooga, TN 37415 Phone: 423-870-5647 | |
Alexia Flangini, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-5437 Fax: 423-778-7507 | |
James H Broom, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 Bell Ave, Chattanooga, TN 37405 Phone: 423-756-2740 Fax: 423-756-4854 | |
Dr. Yuchun Han, M.D. & PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1626 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-698-8747 Fax: 423-698-8847 | |
Sharon Nancy Farber, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 513 Dodds Ave Ste 103, Chattanooga, TN 37404 Phone: 423-698-3423 Fax: 423-698-1380 |